CASP8 and BRD1

Number of citations of the paper that reports this interaction (PubMedID 32296183)
86

Data Source:
BioGRID (two hybrid)

		CASP8	BRD1
Description		caspase 8	bromodomain containing 1
Image
GO Annotations	Cellular Component	Nucleoplasm Cytoplasm Mitochondrion Mitochondrial Outer Membrane Cytosol Cytoskeleton Death-inducing Signaling Complex CD95 Death-inducing Signaling Complex Protein-containing Complex Neuron Projection Cell Body Membrane Raft Ripoptosome	Nucleus Chromosome Nuclear Speck Dendrite Histone H3-K14 Acetyltransferase Complex Perikaryon MOZ/MORF Histone Acetyltransferase Complex
	Molecular Function	Cysteine-type Endopeptidase Activity Death Receptor Binding Tumor Necrosis Factor Receptor Binding Protein Binding Peptidase Activity Cysteine-type Peptidase Activity Ubiquitin Protein Ligase Binding Death Effector Domain Binding Identical Protein Binding Protein-containing Complex Binding Scaffold Protein Binding Cysteine-type Endopeptidase Activity Involved In Apoptotic Process Cysteine-type Endopeptidase Activity Involved In Apoptotic Signaling Pathway Cysteine-type Endopeptidase Activity Involved In Execution Phase Of Apoptosis	Protein Binding Histone Binding Metal Ion Binding
	Biological Process	Angiogenesis Regulation Of Cytokine Production Proteolysis Apoptotic Process Activation Of Cysteine-type Endopeptidase Activity Involved In Apoptotic Process Heart Development Extrinsic Apoptotic Signaling Pathway Via Death Domain Receptors Response To Cold Regulation Of Tumor Necrosis Factor-mediated Signaling Pathway Natural Killer Cell Activation Macrophage Differentiation Response To Cobalt Ion Response To Estradiol Response To Lipopolysaccharide Positive Regulation Of Interleukin-1 Beta Production Response To Tumor Necrosis Factor TRAIL-activated Apoptotic Signaling Pathway T Cell Activation B Cell Activation Positive Regulation Of Apoptotic Process Positive Regulation Of I-kappaB Kinase/NF-kappaB Signaling Negative Regulation Of I-kappaB Kinase/NF-kappaB Signaling Regulation Of Innate Immune Response Response To Ethanol Positive Regulation Of Macrophage Differentiation Positive Regulation Of Proteolysis Response To Antibiotic Proteolysis Involved In Cellular Protein Catabolic Process Negative Regulation Of Necroptotic Process Syncytiotrophoblast Cell Differentiation Involved In Labyrinthine Layer Development Pyroptosis Cellular Response To Mechanical Stimulus Cellular Response To Organic Cyclic Compound Apoptotic Signaling Pathway Extrinsic Apoptotic Signaling Pathway Execution Phase Of Apoptosis Activation Of Cysteine-type Endopeptidase Activity Self Proteolysis Positive Regulation Of Neuron Death	Response To Immobilization Stress Erythrocyte Maturation Histone H3 Acetylation Histone H3-K14 Acetylation Positive Regulation Of Erythrocyte Differentiation Response To Electrical Stimulus
Pathways		Apoptotic cleavage of cellular proteins Caspase activation via Death Receptors in the presence of ligand NOD1/2 Signaling Pathway TRIF-mediated programmed cell death Caspase-mediated cleavage of cytoskeletal proteins Regulation by c-FLIP RIPK1-mediated regulated necrosis CASP8 activity is inhibited TNFR1-induced proapoptotic signaling Regulation of TNFR1 signaling CLEC7A/inflammasome pathway Regulation of necroptotic cell death Dimerization of procaspase-8 Activation, myristolyation of BID and translocation to mitochondria Apoptotic execution phase FasL/ CD95L signaling TRAIL signaling TLR3-mediated TICAM1-dependent programmed cell death NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 Microbial modulation of RIPK1-mediated regulated necrosis Defective RIPK1-mediated regulated necrosis	HATs acetylate histones Regulation of TP53 Activity through Acetylation
Drugs		Bryostatin 1 Bardoxolone
Diseases
GWAS		Basal cell carcinoma ( 33549134 28177523 25855136) Breast cancer ( 29059683) Chronic lymphocytic leukemia ( 28165464 26956414 23770605) Cutaneous malignant melanoma ( 32341527) Esophageal squamous cell carcinoma ( 25129146) Lymphocyte counts ( 27863252) Melanoma ( 21983787 28212542) Multiple sclerosis ( 31604244) Neutrophil percentage of white cells ( 32888494) Nevus count or cutaneous melanoma ( 32341527 30429480) Non-small cell lung cancer ( 31326317) Plateletcrit ( 32888494) Prostate cancer ( 29892016) Rheumatoid arthritis ( 30423114 24390342) Spleen volume ( 34128465) White blood cell count ( 32888494)	Acne (severe) ( 24927181) Mean platelet volume ( 27863252) Metabolite levels ( 23823483) Natriuretic peptide levels ( 21273288) Pulse pressure ( 30224653) Schizophrenia ( 23894747) Urinary albumin excretion ( 32277301) Youthful appearance (self-reported) ( 32339537)
Interacting Genes		140 interacting genes: AGR3 ANGPTL4 AP1M1 APAF1 APP AR ATAD2 ATG4D ATP1A3 BAP1 BCAP31 BCL2 BCL2L1 BCL2L10 BEX1 BFAR BID BIRC6 BLID BMPR2 BRD1 CASC3 CASP1 CASP10 CASP14 CASP2 CASP3 CASP4 CASP6 CASP7 CASP8AP2 CASP9 CCNL1 CDH1 CDH13 CDK11B CDKN1B CFLAR CHD3 CHUK CNBP COPS6 CRADD CTNNB1 DDX5 DEDD DEDD2 EDA2R EIF2AK2 EPSTI1 ERBB4 ERRFI1 FADD FAF1 FAS FYN GLCE GMEB1 GREB1 GRIA1 GZMB HBP1 HDAC7 HECTD3 HIP1 IFT57 IKBKB IKBKG IL13RA2 IL24 ILK KLK5 KLK9 KRT18 LYPD3 MAP1LC3B MAP3K14 MAP4K4 MAPK1 MAPK3 MAPT NOD1 NOL3 NR1H4 NSD3 OGT PARK7 PARP1 PARP2 PCYT1A PDIA6 PEA15 PIAS1 PICALM PIK3C3 PLA2G4B PLEC PLIN4 PRDM14 PRDX6 PRKCI PRKCZ PRKN PRRX2 PRSS50 PSEN1 PSEN2 PSMC3IP QDPR RALBP1 RB1 RIPK1 RIPK2 RNF31 RYBP S100A14 SCGB2A2 SERPINB5 SNRPD3 SNX19 SOX2 SRC SRF ST14 STK24 SUMO1 TFCP2 TNFRSF10A TNFRSF10B TOPORS TRAF1 TRAF2 TRAF6 UBC UMPS USO1 VIM VPS45 YBX1 ZNF707	17 interacting genes: CASP8 CEP126 CEP70 DISC1 FEZ1 FEZ2 H2AX H3C14 HMBOX1 MAGEA11 PICK1 RUBCN SS18L1 TFIP11 VIM ZNF512B ZRANB1
Entrez ID		841	23774
HPRD ID		03459	06848
Ensembl ID		ENSG00000064012	ENSG00000100425
Uniprot IDs		A0A024R3Z8 Q14790	A0A024R4V5 A0A024R4W4 O95696 Q59G93
PDB IDs		1F9E 1I4E 1QDU 1QTN 2C2Z 2FUN 2K7Z 2Y1L 3H11 3KJN 3KJQ 4JJ7 4PRZ 4PS1 4ZBW 5H31 5H33 5JQE 5L08 6AGW 6PX9	2KU3 2L43 2LQ6 3LYI 3RCW 4Z02 5AME 5AMF 5FG6 5GK9 5N49 5PNX 5PNY 5PNZ 5PO0 5PO1 5PO2 5PO3 5PO4 5PO5 5PO6 5PO7 5PO8 5PO9 5POA 5POB 5POC 5POD 5POE 5POF 5POG 5POH 5POI 5POJ 5POK 5POL 5POM 5PON 5POO 5POP 5POQ 5POR 5POS 5POT 5POU 5POV 5POW 5POX 5POY 5POZ 5PP0 5PP1 5PP2 5PP3 5PP4 5PP5 5PP6 5PP7 5PP8 5PP9 5PPA 5PPB 5PPC 5PPD 5PPE 5PPF 5PPG 5PPH 5PPI 5PPJ 5PPK 5PPL 5PPM 5PPN 5PPO 5PPP 5PPQ 5PPR 5PPS 5PPT 5PPU 5PPV 5PPW 5PPX 5PPY 5PPZ 5PQ0 5PQ1 5PQ2 5PQ3 5PQ4 5PQ5 5PQ6 5PQ7 5PQ8 5PQ9 5PQA 5PQB 5PQC 5PQD 5PQE 5PQF 5PQG 5PQH 5PQI 5PQJ 5PQK 5PQL 5PQM 5PQN 5PQO 5PQP 5PQQ 5PQR 5PQS 5PQT 5PQU 5PQV 5PQW 5PQX 5PQY 5PQZ 5PR0 5PR1 5PR2 5PR4 5PR5 5PR6 5PR7 5PR8 5PR9 5PRA 5PRB 5PRD 5PRE 5PRF 5PRG 5PRH 5PRI 5PRJ 5PRK 5PRL 5PRM 5PRO 5PRP 5PRQ 5PRR 5PRS 5PRT 5PRU 5PRV 5PRW 5PRX 5PRY 5PRZ 5PS0 5PS1 5PS2 5PS3 5PS4 5PS5 5PS6 5PS7 5PS8 5PS9 5PSA 5PSB 5PSC 5PSD 5PSE 5PSF 5PSG 5PSH 5PSI 5PSJ 5PSK 5PSL 5PSM 5PSN 5PSO 5PSP 5PSQ 5PSR 5PSS 5PST 5PSU 5PSV 5PSW 5PSX 5PSY 5PSZ 5PT0 5PT1 5PT2 5PT3 5PT4 5PT5 5PT6 5PT7 5PT8 5PT9 5PTA 5PTB 5PTC 5PTE 5PTF 5PTG 5PTH 5PTJ 5PTK 5PTL 5PTM 5PTN 5PTO 5PTQ 5PTR 5PTS 5PTT 5PTU 5PTV 5PTW 5PTX 5PTY 5PTZ 5PU0 5PU1 5PU2 5PU3 5PU4 5PU5 5PU6 5PU7 5PU8 5PU9 5PUA 5PUB 5PUC 5PUD 5PUE 5PUF 5PUG 5PUH 5PUI 5PUJ 5PUK 5PUL 5PUM 5PUN 5PUO 5PUP 5PUQ 5PUR 5PUS 5PUT 5PUU 5PUV 5PUW 5PUX 5PUY 5PUZ 5PV0 5PV1 5PV2 5PV3 5PV4 5PV5 5PV6 5PV7 5PV8 5PV9 5PVA 5PVB 5PVC 5PVD 5PVE 5PVF 5PVG 5PVH 5PVI 5PVJ 5PVK 5PVL 5PVM 5PVN 5PVO 5PVP 5PVQ 5PVR 5PVS 5PVT 5PVU 5PVV 5PVW 5PVX 5PVY 5PVZ 5PW0 5PW1 5PW2 5PW3 5PW4 5PW5 5PW6 5PW7 5PW8 5PW9 5PWA 5PWB 6IN2 6MAJ 6MAK 7LH9
Enriched GO Terms of Interacting Partners?
Tagcloud ?
Tagcloud (Difference) ?
Tagcloud (Intersection) ?